Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects

被引：0
|
作者：
Rebecca E. Wrishko
Jacqueline B. McCrea
Ka Lai Yee
Wen Liu
Deborah Panebianco
Eric Mangin
Manu Chakravarthy
Maria P. Martinez-Cantarin
Walter K. Kraft
机构：
[1] Merck & Co.,Department of Pharmacology and Experimental Therapeutics
[2] Inc.,undefined
[3] Thomas Jefferson University,undefined
来源：
Clinical Drug Investigation | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The original version of this article unfortunately contained a mistake
引用
收藏
页码：453 / 454
页数：1
相关论文
共 50 条
  • [21] A Single-Center, Open-Label, Fixed-Sequence Clinical Study to Evaluate the Pharmacokinetic Effects of Supaglutide on Digoxin or Metformin in Healthy Subjects
    He Jinjie
    Zhang Jing
    Anwar, Dilbar
    Wu Haiya
    Wang, Qinghua
    Wu, Xiaojie
    DIABETES, 2024, 73
  • [22] Short-term administration of Polypodium leucotomos extract does not inhibit CYP3A4-mediated metabolism of midazolam in healthy subjects: an open-label, two-period, fixed-sequence study
    Shinya, Koichiro
    Nishimura, Yuki
    Ryu, Kakei
    Sambe, Takehiko
    Fujishiro, Masaya
    Nakauchi, Akihiro
    Kashiwabuchi, Yumika
    Iwase, Mariko
    Chokki, Hirokazu
    Kurata, Norimitsu
    Matsuyama, Takaaki
    Kiuchi, Yuji
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (05) : 694 - 699
  • [23] Phase I Studies of Acebilustat: Pharmacokinetics, Pharmacodynamics, Food Effect, and CYP3A Induction
    Elborn, J. S.
    Bhatt, L.
    Grosswald, R.
    Ahuja, S.
    Springman, E. B.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2017, 10 (01): : 20 - 27
  • [24] Effect of Food on the Pharmacokinetics of Tenofovir Amibufenamide: A Phase I, Randomized, Open-Label, Two-Period Crossover Trial in Healthy Adult Subjects
    Liu, Jian
    Wu, Minglan
    Kai, Jiejing
    Lin, Meihua
    Zheng, Yunliang
    Jiang, Yiya
    Huang, Qian
    Zhai, You
    Qiu, Yunqing
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 3061 - 3072
  • [25] A phase I open-label fixed sequence two-period crossover study of the effect of multiple doses of modafinil on palbociclib (PD-0332991) pharmacokinetics in healthy volunteers
    Hoffman, Justin T.
    Loi, Cho-Ming
    Plotka, Anna
    O'Gorman, Melissa
    Shi, Haihong
    Mori, Ave
    Wang, Diane D.
    CANCER RESEARCH, 2016, 76
  • [26] Effect of CYP3A4 induction and inhibition on the pharmacokinetics of SHR0302 in healthy subjects
    Zhang, Zhe
    Gao, Xuehu
    Zhang, Ping
    Li, Yuan
    Fu, Meng
    Lin, Hongda
    Feng, Sheng
    Shen, Kai
    Yu, Guoning
    Li, Xin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (08) : 2561 - 2568
  • [27] Effect of Roxadustat on the Pharmacokinetics of Simvastatin, Rosuvastatin, and Atorvastatin in Healthy Subjects: Results From 3 Phase 1, Open-Label, 1-Sequence, Crossover Studies
    Groenendaal-van de Meent, Dorien
    den Adel, Martin
    Kerbusch, Virginie
    van Dijk, Jan
    Shibata, Tomohisa
    Kato, Kota
    Schaddelee, Marloes
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (04): : 486 - 501
  • [28] The effect of itraconazole on the pharmacokinetics of lorlatinib: results of a phase I, open-label, crossover study in healthy participants
    Patel, Maulik
    Chen, Joseph
    McGrory, Stephanie
    O'Gorman, Melissa
    Nepal, Sunil
    Ginman, Katherine
    Pithavala, Yazdi K.
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (01) : 131 - 139
  • [29] The effect of itraconazole on the pharmacokinetics of lorlatinib: results of a phase I, open-label, crossover study in healthy participants
    Maulik Patel
    Joseph Chen
    Stephanie McGrory
    Melissa O’Gorman
    Sunil Nepal
    Katherine Ginman
    Yazdi K. Pithavala
    Investigational New Drugs, 2020, 38 : 131 - 139
  • [30] Pharmacokinetics of Single and Multiple Doses of Omega-3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open-Label Study
    Jing, Shan
    Zhang, Zhenxian
    Chen, Xiaowen
    Miao, Rui
    Nilsson, Catarina
    Lin, Yang
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (08): : 985 - 994
12345